Skip to content

A Study to compare the effectiveness of two Ayurvedic Medicines Patola triphaladi Kashaya and Amrtavrishadi Kashaya in Urticaria

A Comparative Clinical Trial to evaluate the effectiveness of Patola triphaladi Kashaya in comparison to Amrtavrishadi Kashaya in Urticaria - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107515
Enrollment
122
Registered
2026-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

None listed

Sponsors

Dr JEEVAN K G
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with signs and symptoms of Urticaria Both male and female participants between the age group of 18-70 presenting with less than 50 wheals along with and symptoms such as itching, rashes, dermatographism

Exclusion criteria

Exclusion criteria: Participants on continuous allopathic medications for urticaria Participants having history of anaphylaxis and urticarial vasculitis Participants having drug allergy Participants with uncontrolled systemic illness Patients not co-operating with the study Pregnant women and lactating mothers Others dermatological conditions like contact dermatitis, allergic eczema, angioedema

Design outcomes

Primary

MeasureTime frame
Change in severity of urticaria symptoms (itching, wheals,rashes,dermatographism)using a predefined symptom grading scaleTimepoint: from baseline to day 15, day 30, day 45 and day 60

Secondary

MeasureTime frame
change in Urticaria Activity scoreTimepoint: during baseline (Day 1-7), during treatment (Day 39 -45), and end of study (Day 53 -59);Change in serum IgE levelsTimepoint: from Baseline (Day 0) to day 60

Countries

India

Contacts

Public ContactDr N VIMALA

Glocal College of Ayurvedic Medical Science and Research Centre

jeevanjeevanss@gmail.com9961993323

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026